checkAd

    DGAP-Adhoc  124  0 Kommentare Eckert & Ziegler Receives Technetium Generator Licenses for Brazil

    DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Strategic Company Decision/Miscellaneous
    Eckert & Ziegler Receives Technetium Generator Licenses for Brazil

    12-Apr-2021 / 21:12 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.


    Sao Paulo, 12 April 2021 - The Brazilian regulator ANVISA has provided Eckert & Ziegler Brasil Comercial Ltda., a fully owned subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), with a license to import and distribute technetium generators. This is the second license ever given to an organization in Brazil, and only the first one for a private company. Technetium generators are a core component for a nuclear imaging procedure called SPECT, which is used for the detection of medical abnormalities. In Brazil, the SPECT market has a volume of about 100 mm Euro annually. Eckert & Ziegler already services about 500 hospitals and clinics in this country with medical devices and radioisotopes, and hopes to start shipping SPECT products in the third quarter of 2021.

    Contact:
    Eckert & Ziegler AG, Karolin Riehle, Investor Relations
    Robert-Rössle-Str. 10, 13125 Berlin, Germany
    Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Eckert&Ziegler!
    Long
    30,96€
    Basispreis
    0,31
    Ask
    × 10,87
    Hebel
    Short
    36,39€
    Basispreis
    0,33
    Ask
    × 10,21
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.


    Information and Explanation of the Issuer to this News:

    Claudia Goulart, CEO of Eckert & Ziegler Brasil, commented: 'We are very excited that Eckert & Ziegler has now been given the opportunity to service the Brazilian nuclear medicine community with SPECT products. It compliments perfectly our existing portfolio of radiopharmaceuticals, among them Lu-177 and O-18, and the services we provide for international pharmaceutical companies'.


    12-Apr-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de


    Language: English
    Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
    Robert-Rössle-Str.10
    13125 Berlin
    Germany
    Phone: +49 30 941084-138
    Fax: +49 30 941084-112
    E-mail: karolin.riehle@ezag.de
    Internet: www.ezag.de
    ISIN: DE0005659700
    WKN: 565970
    Indices: SDAX
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1183796

     
    End of Announcement DGAP News Service

    1183796  12-Apr-2021 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1183796&application_name=news&site_id=wallstreet

    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-Adhoc Eckert & Ziegler Receives Technetium Generator Licenses for Brazil DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Strategic Company Decision/Miscellaneous Eckert & Ziegler Receives Technetium Generator Licenses for Brazil 12-Apr-2021 / 21:12 CET/CEST Disclosure of an inside …

    Schreibe Deinen Kommentar

    Disclaimer